Thailand - Delayed Quote THB

Praram 9 Hospital Public Company Limited (PR9-R.BK)

24.60
+0.20
+(0.82%)
At close: 4:38:27 PM GMT+7
Loading Chart for PR9-R.BK
  • Previous Close 24.40
  • Open 24.40
  • Bid --
  • Ask --
  • Day's Range 24.10 - 24.70
  • 52 Week Range 24.10 - 24.70
  • Volume 1,925,500
  • Avg. Volume --
  • Market Cap (intraday) 19.343B
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) 52.56
  • EPS (TTM) 0.47
  • Earnings Date Aug 6, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 7, 2025
  • 1y Target Est --

Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as vaccination and travel medicine, and traditional Chinese medicine clinics. It is also involved in the operation of kidney disease and transplantation, cardiovascular, and pain management and wellness institutes. Praram 9 Hospital Public Company Limited was founded in 1992 and is based in Bangkok, Thailand.

www.praram9.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PR9-R.BK

View More

Compare To: PR9-R.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PR9-R.BK

View More

Valuation Measures

Annual
As of 6/4/2025
  • Market Cap

    19.19B

  • Enterprise Value

    16.61B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.51%

  • Return on Assets (ttm)

    8.54%

  • Return on Equity (ttm)

    13.87%

  • Revenue (ttm)

    4.86B

  • Net Income Avi to Common (ttm)

    754.15M

  • Diluted EPS (ttm)

    0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.59B

  • Total Debt/Equity (mrq)

    0.17%

  • Levered Free Cash Flow (ttm)

    626.43M

Research Analysis: PR9-R.BK

View More

Company Insights: PR9-R.BK

Research Reports: PR9-R.BK

View More

People Also Watch